Membership

Newsletters

February 2015 Newsletter

Dear Colleagues,

Time is flying! The World Conference in Denver is coming closer, and we hope as many as possible will join us for this conference. Two of our global initiatives will be presented in Denver: the new staging system for lung cancer and thymic cancers, and the new WHO Multidisciplinary Histo-pathologic Classification.

January 2015 Newsletter

This year, the results from two large IASLC projects will be presented. The IASLC Staging Committee, under the leadership of Dr. Rami-Porta, will present the new staging system for lung cancer,

December 2014 Newsletter

As we approach the end of the year, I am very proud to share with you that this year has been a very successful year for IASLC!
Our meetings, both regional meetings and smaller meetings/workshops, have been very successful in terms of science and attendance. For the next year we will have the World Conference in September; we will continue our more “traditional” smaller meetings; we will also expand the focused meetings, which will include an expert meeting on Small Cell Lung Cancer in April in New York City, and we will also plan for a specific immunotherapy meeting in the fall of 2015.

November Member Newsletter

Over the last month IASLC had two successful events; the ASTRO/ASCO/IASLC Multidisciplinary Meeting in Chicago, which had about 800 participants and the Asian Pacific Lung Cancer Meeting (APLCC) in Kuala Lumpur with about the same number of participants. Kudos to Dr. Karen Kelly chairing the Chicago meeting and to Drs. Liam and Ibrahim chairing the APLCC meeting in KL. IASLC will continue to grow the regional meetings, which is an important mission of our organization.

October Newsletter

September 2014 Newsletter

Dear Colleagues,

While many activities within IASLC are ongoing, the last month has notably been a success for IASLC in Asia. A very successful IASLC workshop on personalized therapy in lung cancer was held in Shanghai under the leadership of Professor Caicun Zhou, and a few weeks ago the Chinese Society of Clinical Oncology (CSCO) held its Annual Meeting with more than 20,000 participants. The program included an IASLC/CSCO session on molecular targeted-therapies in NSCLC. Thanks to Professor Yi-Long Wu, who is now also President of CSCO, and to the IASLC President Professor Tony Mok, who is now also vice-president of CSCO, for establishing this very exciting session at CSCO. The IASLC/CSCO session drew a fully packed audience.

Pages